Infinity Pharmaceuticals Inc (INFI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access INFI Annual Balance Sheets →
From Infinity Pharmaceuticals Inc through Jun 30 2022, shifts in Jun 30 2023's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Assets
Cash & cash equivalent17.75
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments17.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.16
Total Current Assets19.91
Equipment/Property/Plant Net0.59
Long-term investments0.16
Other Assets, Noncurrent0.74
Total Assets21.23
Liabilities
Accounts Payable, Current AC1.50
Total Current Liabilities12.06
Total Long-term Debt0.00
Other liabilities, Noncurrent46.57
Accrued Liabilities And Other Current Liabilities10.56
Total Liabilities58.64
Stockholders' Equity
Common Stock Value0.09
Additional Paid In Capital Common Stock839.46
Retained Earnings / Accumulated Deficit-876.95
Other Equity0.00
Common Stockholder's Equity-37.41
Total Stockholder's Equity-37.41
Liabilities & Stockholder's Equity21.23
4 historic quarters locked

Sign in to unlock the full Infinity Pharmaceuticals Inc balance sheet history.

About Infinity Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001113148-23-000009

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.